Events

Loading Events

Past Events › Webinars

Find Events

Event Views Navigation

Past Events › Webinars

April 2018

The Use of Human iPSC-derived Motor Neurons for Translational Research

Webinars
April 9, 2018 | 10:00 am CDT - 11:00 am CDT

In this webinar, Dr. Kevin Eggan will discuss the derivation and characterization of motor neurons from iPS cells and the use of these cells in ALS disease models and translational research. Topics covered: Characterization of iPSC-derived motor neurons Use of iPSC-derived Motor Neurons to generate ALS disease models iPSC-derived Motor Neurons in translational research

Find out more »

January 2018

iPSC-derived Retinal Pigment Epithelial Cells in Research and Clinical Applications

Webinars
January 12, 2018 | 1:00 pm CST - 2:00 pm CST

In this webinar, Dr. Kapil Bharti discussed the use of induced pluripotent stem (iPS) cell technology to develop in vitro disease models to study patient-specific disease processes, to set up high throughput drug screens, and to develop cell-based therapy for retinal degenerative disease. Topics covered: Characterization of iPSC-derived retinal pigment epithelium (RPE) iPSC-derived RPE for ocular disease modeling iPSC-derived RPE in clinical applications For access to the video recording of this webinar, please register here.

Find out more »

December 2017

Rapid and Reliable Neurotoxicity Detection

Webinars
December 6, 2017 | 9:00 am CST - 10:00 am CST

Human iPSC neurons provide robust solutions to predict drug-induced disruption of electrical, structural, and functional processes. Neurotoxicity has been difficult to detect with traditional methods and remains a primary cause of late-stage and post-launch drug attrition. The iCell® portfolio of subtype-specific human neurons provides new models for early and accurate detection of multiple forms of neurotoxicity. This seminar will focus on CDI’s iCell GABANeurons and iCell GlutaNeurons as tools for detecting structural (neurite outgrowth) and electrical (seizurogenesis) toxicities as well…

Find out more »

September 2017

Exploring the Role of iPSC-Cardiomyocytes in Drug Discovery and Safety Assessment

Webinars
September 7, 2017 | 11:00 am CDT - 12:00 pm CDT

Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are increasingly utilized in drug discovery, safety assessment of pharmaceutical compounds, and studies of disease mechanisms. The opportunity to measure the contractility, viability, and electrophysiology of these cells in real time over extended periods provides researchers with additional mechanistic insights into the roles cardiomyocytes play in both normal development and cardiac disease, in addition to providing incisive information regarding drug efficacy and toxicity. In this special webinar, scientists using hiPSC-CMs will describe novel…

Find out more »

January 2017

Modeling Lipid and Glucose Metabolism Using Human iPSC-derived Hepatocytes

Webinars
January 25, 2017 | 10:00 am CST - 11:00 am CST

The study of metabolic disease is changing as limitations of classical in vitro cell models are increasingly evident, causing investigators to search for improved alternatives. Induced pluripotent stem cells (iPSCs) are the logical alternative for advancing basic biology and applied biomedical research through the development of relevant human cell models. Recapitulating native physiological behavior is the ideal scenario for phenotypic screening and target identification—techniques that are paramount to both academic and biopharmaceutical researchers. Join us for this GEN webinar, where we will focus…

Find out more »
+ Export Events